These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 27249229)
1. Epidemiological Investigation and Risk Factors for Cervical Lesions: Cervical Cancer Screening Among Women in Rural Areas of Henan Province China. Zhang Q; Xie W; Wang F; Li RH; Cui L; Wang H; Fu X; Song J Med Sci Monit; 2016 Jun; 22():1858-65. PubMed ID: 27249229 [TBL] [Abstract][Full Text] [Related]
2. [Real-world research on cervical cancer screening program and effect evaluation for Chinese population]. Zhao YQ; Dai Y; Dang L; Kong LH; Zhang Y; Feng RM; Qiao YL; Lang JH Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):764-771. PubMed ID: 30392341 [No Abstract] [Full Text] [Related]
3. Evaluation of portable colposcopy and human papillomavirus testing for screening of cervical cancer in rural China. Newman H; Hu J; Li X; He J; Bradford L; Shan S; Wu X; Zhu B; Yang W; Fu B; Zhu B; Gao G Int J Gynecol Cancer; 2019 Jan; 29(1):23-27. PubMed ID: 30640679 [TBL] [Abstract][Full Text] [Related]
4. Application of human papillomavirus in screening for cervical cancer and precancerous lesions. Wang JL; Yang YZ; Dong WW; Sun J; Tao HT; Li RX; Hu Y Asian Pac J Cancer Prev; 2013; 14(5):2979-82. PubMed ID: 23803065 [TBL] [Abstract][Full Text] [Related]
5. [Investigation on the prevalence of high risk human papillomavirus and cervical cancer among adult women, in Shenzhen]. DU H; Wu RF; Tang HR; Wu LN; Zhang LJ; Liu ZH; Li J; Li RZ; Wang GP; Zhou YQ; Wang C; Weng LM Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Aug; 33(8):799-802. PubMed ID: 22967332 [TBL] [Abstract][Full Text] [Related]
6. Introduction of liquid-based cytology and human papillomavirus testing in cervical cancer screening in Luxembourg. Latsuzbaia A; Hebette G; Fischer M; Arbyn M; Weyers S; Vielh P; Schmitt F; Mossong J Diagn Cytopathol; 2017 May; 45(5):384-390. PubMed ID: 28247516 [TBL] [Abstract][Full Text] [Related]
7. Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting. Leinonen M; Nieminen P; Kotaniemi-Talonen L; Malila N; Tarkkanen J; Laurila P; Anttila A J Natl Cancer Inst; 2009 Dec; 101(23):1612-23. PubMed ID: 19903804 [TBL] [Abstract][Full Text] [Related]
8. [Study on the value assessment of various screening programs regarding cervical cancer screening strategy in the rural areas of China]. Li LY; Qiao ZQ; Zhang MF; Yang JP; Bao YP; An YT; Lei J; Xiong NH; Yu XH; Zhang X; Pan QJ; Qiao YL Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Oct; 28(10):964-7. PubMed ID: 18399140 [TBL] [Abstract][Full Text] [Related]
9. Co-infection with trichomonas vaginalis increases the risk of cervical intraepithelial neoplasia grade 2-3 among HPV16 positive female: a large population-based study. Yang M; Li L; Jiang C; Qin X; Zhou M; Mao X; Xing H BMC Infect Dis; 2020 Sep; 20(1):642. PubMed ID: 32873233 [TBL] [Abstract][Full Text] [Related]
10. Cervical cancer awareness and presence of abnormal cytology among HIV-infected women on antiretroviral therapy in rural Andhra Pradesh, India. Shin SS; Carpenter CL; Ekstrand ML; Wang Q; Grover S; Zetola NM; Yadav K; Sinha S; Nyamathi AM Int J STD AIDS; 2019 May; 30(6):586-595. PubMed ID: 30813859 [TBL] [Abstract][Full Text] [Related]
11. HPV DNA Testing and Mobile Colposcopy for Cervical Precancer Screening in HIV Positive Women: A Comparison Between Two Settings in Ghana and Recommendation for Screening. Effah K; Anthony R; Tekpor E; Amuah JE; Wormenor CM; Tay G; Kraa SEY; Katso AM; Akonnor CA; Kemawor S; Danyo S; Atuguba BH; Essel NOM; Akakpo PK Cancer Control; 2024; 31():10732748241244678. PubMed ID: 38563112 [TBL] [Abstract][Full Text] [Related]
12. Three-year risk of high-grade CIN for women aged 30 years or older who undergo baseline Pap cytology and HPV co-screening. Guo M; Khanna A; Wang J; Dawlett MA; Kologinczak TL; Lyons GR; Bassett RL; Sneige N; Gong Y; Bevers TB Cancer Cytopathol; 2017 Aug; 125(8):644-651. PubMed ID: 28498639 [TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus prevalence and type-distribution among women in Zhejiang Province, Southeast China: a cross-sectional study. Liu XX; Fan XL; Yu YP; Ji L; Yan J; Sun AH BMC Infect Dis; 2014 Dec; 14():708. PubMed ID: 25523884 [TBL] [Abstract][Full Text] [Related]
14. Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial. Canfell K; Caruana M; Gebski V; Darlington-Brown J; Heley S; Brotherton J; Gertig D; Jennett CJ; Farnsworth A; Tan J; Wrede CD; Castle PE; Saville M PLoS Med; 2017 Sep; 14(9):e1002388. PubMed ID: 28926579 [TBL] [Abstract][Full Text] [Related]
15. Benefit and burden in the Dutch cytology-based vs high-risk human papillomavirus-based cervical cancer screening program. Loopik DL; Koenjer LM; Siebers AG; Melchers WJG; Bekkers RLM Am J Obstet Gynecol; 2021 Feb; 224(2):200.e1-200.e9. PubMed ID: 32800820 [TBL] [Abstract][Full Text] [Related]
16. A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China. Qiao YL; Sellors JW; Eder PS; Bao YP; Lim JM; Zhao FH; Weigl B; Zhang WH; Peck RB; Li L; Chen F; Pan QJ; Lorincz AT Lancet Oncol; 2008 Oct; 9(10):929-36. PubMed ID: 18805733 [TBL] [Abstract][Full Text] [Related]
17. The IMproving Primary Screening And Colposcopy Triage trial: human papillomavirus, cervical cytology, and histopathologic results from the baseline and 1-year follow-up phase. Safaeian M; Wright TC; Stoler MH; Ranger-Moore J; Rehm S; Aslam S; Fang Q; Volkir P; Ridder R Am J Obstet Gynecol; 2021 Sep; 225(3):278.e1-278.e16. PubMed ID: 33852886 [TBL] [Abstract][Full Text] [Related]
18. Prevalence and risk factors for cervical intraepithelial neoplasia among HIV-infected women. Teixeira NC; Araújo AC; Correa CM; Lodi CT; Lima MI; Carvalho Nde O; Castillo DM; Melo VH Braz J Infect Dis; 2012; 16(2):164-9. PubMed ID: 22552459 [TBL] [Abstract][Full Text] [Related]
19. Screening of cervical neoplasia in HIV-infected women in India. Joshi S; Sankaranarayanan R; Muwonge R; Kulkarni V; Somanathan T; Divate U AIDS; 2013 Feb; 27(4):607-15. PubMed ID: 23079814 [TBL] [Abstract][Full Text] [Related]
20. Shanxi Province Cervical Cancer Screening Study: a cross-sectional comparative trial of multiple techniques to detect cervical neoplasia. Belinson J; Qiao YL; Pretorius R; Zhang WH; Elson P; Li L; Pan QJ; Fischer C; Lorincz A; Zahniser D Gynecol Oncol; 2001 Nov; 83(2):439-44. PubMed ID: 11606114 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]